Skip to content
Disclosery

EXANE DERIVATIVES: NFLX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NFLX, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 423 NFLX shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 423 shares
    Change vs previous 13F -444 shares

    0.04% of the 13F portfolio, value $73,954.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 867 shares
    Change vs previous 13F -64 shares

    0.09% of the 13F portfolio, value $324,745.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 931 shares
    Change vs previous 13F +283 shares

    0.14% of the 13F portfolio, value $560,844.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 648 shares
    Change vs previous 13F -396 shares

    0.1% of the 13F portfolio, value $395,481.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,044 shares
    Change vs previous 13F -923 shares

    0.13% of the 13F portfolio, value $564,452.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,967 shares
    Change vs previous 13F not available

    0.31% of the 13F portfolio, value $1,026,043.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).